Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine, Los Angeles, California, USA.
J Virol. 2010 Sep;84(17):8945-8. doi: 10.1128/JVI.00244-10. Epub 2010 Jun 23.
Myc is deregulated by Kaposi's sarcoma-associated herpesvirus (KSHV) latent proteins, but its role in KSHV latency is not clear. We found that Myc knockdown with RNA interference (RNAi) induced KSHV reactivation and increased the protein and mRNA levels of RTA, a key viral regulator of KSHV reactivation. Myc knockdown increased, whereas Myc overexpression inhibited, RTA promoter activity. KSHV reactivation and the activation of the RTA promoter induced by Myc depletion were inhibited by c-Jun N-terminal kinase (JNK) and p38 inhibitors but not by a MEK1 inhibitor. Myc knockdown inhibited primary effusion lymphoma (PEL) cell proliferation through inducing apoptosis and G(1) cell cycle arrest. Thus, Myc may be a key cellular node coupling cellular transformation and KSHV latency.
Myc 受到卡波西肉瘤相关疱疹病毒 (KSHV) 潜伏蛋白的调节,但它在 KSHV 潜伏中的作用尚不清楚。我们发现,RNA 干扰 (RNAi) 下调 Myc 可诱导 KSHV 再激活,并增加 RTA 的蛋白和 mRNA 水平,RTA 是 KSHV 再激活的关键病毒调节因子。Myc 下调增加,而 Myc 过表达抑制,RTA 启动子活性。Myc 耗竭诱导的 KSHV 再激活和 RTA 启动子的激活被 c-Jun N 端激酶 (JNK) 和 p38 抑制剂抑制,但不被 MEK1 抑制剂抑制。Myc 下调通过诱导细胞凋亡和 G1 细胞周期阻滞来抑制原发性渗出性淋巴瘤 (PEL) 细胞增殖。因此,Myc 可能是连接细胞转化和 KSHV 潜伏的关键细胞节点。